People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phlow Corp. | — | Pharmaceuticals | Series B | $82.8M | $169.5M | 2025 |
| EvidenceCare, Inc. | — | Other Health Care | Series B | $28.0M | $50.8M | 2025 |
Melinda Hancock at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Melinda Hancock on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Ryan | 1 | 9 |
| David Levin | 1 | 7 |
| Eric Edwards | 1 | 3 |
| Dave Vreeland | 1 | 3 |
| Curt Futch | 1 | 3 |
| Donald Lazas | 1 | 2 |
| William Sheahan | 1 | 2 |
| Britt Groomes | 1 | 1 |
| Justin McGoldrick | 1 | 1 |
| Bo Wilkes | 1 | 1 |
| David Vreeland | 1 | 1 |
| James Jamieson | 1 | 1 |
| Marshall Summar | 1 | 1 |
| Judson Ivy | 1 | 1 |
| Cyril Philip | 1 | 1 |
| Robert Maria Demeria | 1 | 1 |
| David Maria Ryan | 1 | 1 |
| Don Lazas | 1 | 1 |
| Bill Sheehan | 1 | 1 |
| Brian Fengler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.